Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...
GLP-1 drug users initially spend less on groceries, but that levels out over the next year, shows Circana's analysis of food ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Danish businesses are concerned about a possible trade conflict with the United States over Greenland, a major lobby group ...
The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...
Midan included 10 trends with implications for the meat industry while identifying two macro-factors that are expected to ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
GoodRx CEO Wendy Barnes outlined the company's priorities at the 2025 JP Morgan Healthcare Conference in San Francisco.
GLP-1 drugs like Ozempic became so popular as weight loss drugs that there was a mid-year shortage. These drugs are also ...
Health is a central focus for some of the UK's largest retailers this year, as nutrition and wellness become a priority for ...
Robert F. Kennedy Jr. has reportedly secured the votes needed for confirmation as Secretary of Health and Human Services (HHS).
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.